Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

41. Davis GC, Williams AC, Markey SP, et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Research. 1979;1(3):249–254.

42. Там же.

43. Designer drugs: hearing before the Committee on the Budget, United States Senate, Ninety-Ninth Congress, first session, July 18, 1985. US Government Publishing Office; 1985.

44. Там же.

45. Sinclair M. Tragedy has designer label. Washington Post. July 19, 1985.

46. Там же.

47. Langston JW, Palfreman J. The Case of the Frozen Addicts: How the Solution of a Medical Mystery Revolutionized the Understanding of Parkinsons Disease. Rev. ed. IOS Press; 2014.

48. Davis GC, Williams AC, Markey SP, et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Research. 1979;1(3):249–254.

49. Там же.

50. Langston JW, Palfreman J. The Case of the Frozen Addicts: How the Solution of a Medical Mystery Revolutionized the Understanding of Parkinsons Disease. Rev. ed. IOS Press; 2014.

51. Designer drugs: hearing before the Committee on the Budget, United States Senate, Ninety-Ninth Congress, first session, July 18, 1985. US Government Publishing Office; 1985.

52. Sinclair M. Tragedy has designer label. Washington Post. July 19, 1985.

53. Davis GC, Williams AC, Markey SP, et al. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Research

. 1979;1(3):249–254.

54. Designer drugs: hearing before the Committee on the Budget, United States Senate, Ninety-Ninth Congress, first session, July 18, 1985. US Government Publishing Office; 1985.

55. Langston JW. The MPTP story. Journal of Parkinsons Disease. 2017;7(s1):S11-S19.

56. Там же.

57. Goldman SM. Environmental toxins and Parkinson’s disease. Annual Review of Pharmacology and Toxicology. 2014;54(1):141–164; Betarbet R, Sherer TB, Mackenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience. 2000;3(12):1301–1306; Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. Parkinson’s disease and brain levels of organochlorine pesticides. Annals of Neurology. 1994;36(1):100–103; Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta– analysis of Parkinson’s disease and exposure to pesticides.

Neurotoxicology. 2000;21(4):435–440.

58. Langston JW. The MPTP story. Journal of Parkinsons Disease. 2017;7(s1):S11-S19.

59. “NOVA; case of the frozen addict, the.” OpenVault from WGBH Boston/ BBC TV. February 18, 1986. http://openvault.wgbh.org/catalog/V_474C F2C8A20B4173988486AC4C605A3C. At 00:55:25.

60. Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson’s disease: an update. Journal of Parkinson’s Disease. 2011;1(1):19–33; Porras G, Li Q, Bezard E. Modeling Parkinson’s disease in primates: the MPTP model. Cold Spring Harbor Perspectives in Medicine. 2012;2(3):a009308.

61. Cornelius CE. Animal models – a neglected medical resource. New England Journal of Medicine. 1969;281(17):934–944; Overall KL. Natural animal models of human psychiatric conditions: assessment of mechanism and validity. Progress in Neuro-psychopharmacology and Biological Psychiatry

. 2000;24(5):727–776.

62. Barre-Sinoussi F, Montagutelli X. Animal models are essential to biological research: issues and perspectives. Future Science OA. 2015;1(4):FSO63-FSO63.

63. Там же.

64. Giasson BI, Lee VMY. A new link between pesticides and Parkinson’s disease. Nature Neuroscience. 2000;3:1227–1228.

65. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience. 2000;3(12):1301–1306.

66. Giasson BI, Lee VMY. A new link between pesticides and Parkinson’s disease. Nature Neuroscience. 2000;3:1227–1228.

67. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6):866–872.

68. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the a-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276(5321):2045–2047.